Aldosterone inhibits nitric oxide synthesis in rat vascular smooth muscle cells induced by interleukin-1 beta.

[1]  U. Ikeda,et al.  Ouabain enhances nitric oxide synthesis in rat vascular smooth muscle cells induced by interleukin-1 beta. , 1995, European journal of pharmacology.

[2]  G. Hansson,et al.  Arterial smooth muscle cells express nitric oxide synthase in response to endothelial injury , 1994, The Journal of experimental medicine.

[3]  M. Yokoyama,et al.  Angiotensin II inhibits cytokine-stimulated inducible nitric oxide synthase expression in vascular smooth muscle cells. , 1994, The Journal of biological chemistry.

[4]  Å. Wennmalm.  Endothelial nitric oxide and cardiovascular disease , 1994, Journal of internal medicine.

[5]  U. Ikeda,et al.  Nitric oxide synthesis in rat cardiac myocytes and fibroblasts. , 1994, Life sciences.

[6]  R. Takeda.  血管におけるauto-/para-crineとしてのステロイド生成とその代謝酵素系 , 1993 .

[7]  M. Yokoyama,et al.  Cyclic AMP-elevating agents induce an inducible type of nitric oxide synthase in cultured vascular smooth muscle cells. Synergism with the induction elicited by inflammatory cytokines. , 1993, The Journal of biological chemistry.

[8]  U. Ikeda,et al.  Regulation of Na,K-adenosine triphosphatase gene expression by sodium ions in cultured neonatal rat cardiocytes. , 1993, The Journal of clinical investigation.

[9]  U. Ikeda,et al.  Regulation of Na-K-ATPase gene expression by aldosterone in vascular smooth muscle cells. , 1993, The American journal of physiology.

[10]  S. Snyder,et al.  Molecular mechanisms of nitric oxide regulation. Potential relevance to cardiovascular disease. , 1993, Circulation research.

[11]  L. Ignarro,et al.  L-arginine inhibits balloon catheter-induced intimal hyperplasia. , 1993, Biochemical and biophysical research communications.

[12]  T. Tsuda,et al.  Cytokine‐induced expression of an inducible type of nitric oxide synthase gene in cultured vascular smooth muscle cells , 1993, FEBS letters.

[13]  T. Sugimura,et al.  Polyclonal antibody against an inducible form of nitric oxide synthase purified from the liver of rats treated with Propionibacterium acnes and lipopolysaccharide. , 1992, Biochemical and biophysical research communications.

[14]  E. Baulieu,et al.  Immunohistochemical and biochemical evidence for a cardiovascular mineralocorticoid receptor. , 1992, Circulation research.

[15]  P. Vanhoutte,et al.  Balloon injury and interleukin-1 beta induce nitric oxide synthase activity in rat carotid arteries. , 1992, Circulation research.

[16]  S. Moncada,et al.  Nitric oxide: physiology, pathophysiology, and pharmacology. , 1991, Pharmacological reviews.

[17]  U. Ikeda,et al.  Interleukin 6 stimulates growth of vascular smooth muscle cells in a PDGF-dependent manner. , 1991, The American journal of physiology.

[18]  D. Harrison,et al.  Diet-induced atherosclerosis increases the release of nitrogen oxides from rabbit aorta. , 1990, The Journal of clinical investigation.

[19]  A. Hassid,et al.  Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. , 1989, The Journal of clinical investigation.

[20]  S. Moncada,et al.  Vascular endothelial cells synthesize nitric oxide from L-arginine , 1988, Nature.

[21]  U. Förstermann,et al.  Selective Attenuation of Endothelium‐Mediated Vasodilation in Atherosclerotic Human Coronary Arteries , 1988, Circulation research.

[22]  V. Dzau,et al.  Endothelial renin-angiotensin pathway: evidence for intracellular synthesis and secretion of angiotensins. , 1987, Circulation research.

[23]  S. Tannenbaum,et al.  Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. , 1982, Analytical biochemistry.

[24]  W. Meyer,et al.  Mineralocorticoid binding in cultured smooth muscle cells and fibroblasts from rat aorta. , 1981, Journal of steroid biochemistry.

[25]  D. Fanestil,et al.  Steroid hormones and the kidney. , 1981, Annual review of physiology.